Characterization of feline herpesvirus-1 deletion mutants in tissue explant cultures

• Published in: Virus research Vol. 284; p. 197981
• Main Authors: Lee, Yao, Maes, Roger, Kiupel, Matti, Nauwynck, Hans, Soboll Hussey, Gisela
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.07.2020
• Subjects: Feline herpesvirus-1; Feline tracheal explant; Glycoprotein E; Serine/threonine protein kinase; Stromal invasion; Thymidine kinase; Serine/threonine protein kinase; FHV-1; IHC; CXCL1; FREC; TCID50; DMEM; HSV-1; ANOVA; PRV; EHV-1; Stromal invasion; WT; Feline tracheal explant; hpi; Thymidine kinase; BAC; MOI; Feline herpesvirus-1; CRFK; gE-TK; IL-10; Glycoprotein E; NC; CPE; PK; gC; ALI; gE; PCR
• ISSN: 0168-1702; 1872-7492
• DOI: 10.1016/j.virusres.2020.197981

•Feline respiratory explants are excellent tools for characterizing FHV-1•Deletion of FHV-1 PK and double-deletion of FHV-1 gE&TK attenuate virulence•Deletion of PK or double-deletion of gE&TK limit stromal invasion of FHV-1•Single-deletions of FHV-1gC or gE do not significantly attenuate tissue damage•FHV-1 PK- and FHV-1 gE-&TK- are promising vaccine candidates for testing in cats Feline herpesvirus-1 (FHV-1) is the primary cause of viral respiratory and ocular disease in cats. While commercial vaccines can provide clinical protection, they do not protect from infection or prevent latency. Moreover, they are not safe for intranasal administration. Our overall objective is to develop a new mucosal vaccine against FHV-1 disease to address these shortcomings. Feline herpesvirus-1 deletion mutants of glycoprotein C (gC-), gE (gE-), US3-encoded serine/threonine protein kinase (PK-), and both gE and thymidine kinase (gE-TK-) were generated by bacterial artificial chromosome (BAC) mutagenesis. Tracheal tissue explants from eight cats were used to compare the pattern of viral infection and associated tissue damage, as well as virus spread through the basement membrane following inoculation with wild-type virus (WT), and gE-, gE-TK-, PK-, and gC- mutants. Tissues were collected at 24, 48, or 72  hours post-inoculation (hpi) followed by immunohistochemistry (IHC) for FHV-1. Histological changes were graded based on the distribution of virus infected cells and the severity of tissue damage. Inoculations with the WT virus resulted in maximal scores at 72 hpi both at a multiplicity of infection (MOI) of 1 and 0.1. Inoculation with the gE- mutant produced scores similar to scores of explants inoculated with the WT virus at 24 and 48 hpi, but scores were significantly decreased at 72 hpi. Explants inoculated with the gE-TK- mutant showed significantly decreased scores at all time points. Further, the majority of explants inoculated with the PK- mutant resulted in scores of zero at all time points, regardless of MOI. Finally, inoculation with WT resulted in significant stromal invasion below the infected epithelium, while stromal invasion was observed in less than 50 % of the samples following inoculation with gE-, gE-TK-, PK-, or gC- mutants and confined closely to the area surrounding the infected epithelium. In conclusion, the gE-TK- and PK- mutants exhibited significantly reduced virulence, tissue damage and spread to the underlying stroma, suggesting that they may be good vaccine candidates for in vivo testing.